|
Volumn 33, Issue 4, 2006, Pages 467-470
|
Gefitinib as a first-line therapy in patients with advanced non-small cell lung cancer
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
GEFITINIB;
QUINAZOLINE DERIVATIVE;
ADULT;
AGED;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
DIARRHEA;
DRUG ADMINISTRATION;
FEMALE;
HUMAN;
KARNOFSKY PERFORMANCE STATUS;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MALE;
MIDDLE AGED;
MORTALITY;
REMISSION;
RETROSPECTIVE STUDY;
SURVIVAL RATE;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS;
CARCINOMA, NON-SMALL-CELL LUNG;
DIARRHEA;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
KARNOFSKY PERFORMANCE STATUS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
QUINAZOLINES;
REMISSION INDUCTION;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
|
EID: 33646350270
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|